High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies

Abstract

Objectives: Borderline ovarian tumors (BOTs) represent 10-20% of all epithelial ovarian malignancies. Most of them are comparable to benign cysts but a high-risk group has been recognized. The aim of the study was to analyze different follow-up strategies in high-risk patients. Method: Patients with BOT treated at our institution from 1992 to 2011 were retrospectively reviewed. Clinicopathological features influencing prognosis were analyzed and two different follow-up strategies compared [6-month laparoscopic look (LPS-look): group A vs. ultrasound/CA-125 evaluation: group B]. Results: 70 patients with high-risk BOTs were identified. After a median progression-free survival (PFS) of 43 months, 27% of patients experienced recurrences. Six months after diagnosis, 26 high-risk patients were submitted to LPS-look: at surgery, 6 out of 10 patients presenting evidence of disease were optimally debulked while in the remaining 4, only biopsies were performed. No difference in PFS was registered between group A and B patients, nevertheless a significant increase in PFS was registered among completely versus incompletely debulked patients with evidence of disease at laparoscopy. Conclusion: Clinical follow-up remains the gold standard for BOTs. These very preliminary data seem to suggest that LPS-look may have an impact on the secondary PFS in a subgroup of high-risk patients.

Management of a borderline ovarian tumor in a pregnant woman in a rural hospital: a case report

“…These tumors account for almost 10%-20% of ovarian neoplasms [2] . There are often seen in young women whom are in childbearing age.…”

Synchronous primary multiple malignancies of colon and ovary followed by acute intestinal obstruction

“…По данным D. Lorusso и соавт. [9], пограничные опухоли яичников составляют 10-20% всех эпителиальных опухолей яичников. При их малигнизации медиана выживаемости равна 43 мес, рецидивы после хирургического лечения бывают в 27% наблюдений.…”